S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer

NCT00058318 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

NETWORK

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: capecitabine
DRUG: gemcitabine hydrochloride

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]